Women in the UK will soon have access to a new daily pill designed to alleviate hot flushes during menopause, following its approval for use.
The Medicines and Healthcare products Regulatory Agency (MHRA) has become the first global regulator to give the green light to elinzanetant, also known as Lynkuet.